All In Biotech

Drug Trial Radar · NCT07933445

VIS954 for Treating Inflammatory Skin Problems

A Phase 2a, Multicenter, Basket Study of VIS954 in Participants With Inflammatory Skin Diseases

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 108 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

108

Planned (sponsor's estimate)

Start

Nov 30, 2026

Primary completion

Mar 13, 2029

Study completion Mar 13, 2029

Sponsor

Sponsor type
Industry
First posted
Nov 12, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a phase 2, multicenter, basket study designed to evaluate the safety, pharmacokinetics, and pharmacodynamics of VIS954 in adults with inflammatory skin diseases (ISDs).

Conditions

  • Inflammatory Skin Diseases

Interventions

  • VIS954Drug

    VIS954 solution for injection

  • PlaceboDrug

    VIS954-matching placebo solution for injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. HS, PG, and BP Cohorts: Incidence Assessed as Number of Adverse Events (AEs) and AEs Related to InfectionTime frame: Up to Week 36
  2. HS, PG, and BP Cohorts: Incidence Assessed as Number of Clinically Significant Laboratory Abnormalities' EventsTime frame: Up to Week 36
  3. HS, PG, and BP Cohorts: Incidence Assessed as Number of Clinically Significant Vital Signs' EventsTime frame: Up to Week 36
  4. HS, PG, and BP Cohorts: Incidence Assessed as Number of Clinically Significant Physical Examination EventsTime frame: Up to Week 36

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.